Mode
Text Size
Log in / Sign up

Infectious Disease

964 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Algorithm development study validates FindPart-w model for identifying SARS-CoV-2 lineage groups in the US
Infectious Disease
Algorithm development study validates FindPart-w model for identifying SARS-CoV-2 lineage groups in the US New tool sorts virus variants by how fast they spread
This algorithm development and validation study evaluates the FindPart-w algorithm and constrained RelRe model against the Pango lineage nom…
A new math tool groups virus variants by how fast they spread instead of just looking at their genetic makeup alone.
Cross-sectional review of mass drug administration impact on lymphatic filariasis elimination in Nepal
Infectious Disease
Cross-sectional review of mass drug administration impact on lymphatic filariasis elimination in Nepal Mass drug administration reduces lymphatic filariasis in most Nepal districts
This cross-sectional epidemiological monitoring survey review assesses lymphatic filariasis transmission in six endemic districts of Nepal f…
A survey of over 7,000 people in Nepal found that mass drug administration lowered infection rates in most areas, though three sites still n…
Review of preclinical FH12-based Sandwich-ELISA for mucormycosis detection
Infectious Disease
Review of preclinical FH12-based Sandwich-ELISA for mucormycosis detection Lab test shows promise for detecting mucormycosis in humans
This preclinical review evaluates an FH12-based Sandwich-ELISA for detecting mucormycosis. The authors report high specificity for pan-Mucor…
A new lab method detects a specific marker for mucormycosis without cross-reacting with other fungi, offering a potential tool for diagnosis…
Nirmatrelvir-ritonavir showed no reduction in hospitalization or death within 28 days for higher-risk adults in community trials.
Infectious Disease RCT
Nirmatrelvir-ritonavir showed no reduction in hospitalization or death within 28 days for higher-risk adults in community trials. New Study Questions Early Use of Paxlovid for Vaccinated Patients
In community-based trials involving higher-risk adults with recent SARS-CoV-2 infection, adding nirmatrelvir-ritonavir to usual care did not…
Getting vaccinated changes how your body fights the virus, and this new research shows that taking Paxlovid early might not be necessary for…
Systematic review and meta-analysis finds higher TB prevalence among people living with HIV in Africa
Infectious Disease Meta-analysis
Systematic review and meta-analysis finds higher TB prevalence among people living with HIV in Africa TB’s Hidden Link: Why HIV Changes the Risk Picture
This systematic review and meta-analysis evaluated bacteriologically-confirmed tuberculosis prevalence in 264,530 people across Southern and…
If you have HIV, your risk of missing a deadly TB diagnosis is far higher—and this study explains why that gap must close now.
Narrative review discusses natural product-based plasmid curing agents versus traditional antibiotic strategies for antimicrobial resistance.
Infectious Disease Sys. Review
Narrative review discusses natural product-based plasmid curing agents versus traditional antibiotic strategies for antimicrobial resistance. How Natural Plants Could Stop Superbugs Without Killing Them
This narrative review examines the potential of natural product-based plasmid curing agents as an alternative to traditional bactericidal an…
This approach could save antibiotics from becoming useless by forcing superbugs to surrender their defenses rather than fighting them.
Narrative review discusses ecological stability limitations and regulatory challenges in field performance.
Infectious Disease Sys. Review
Narrative review discusses ecological stability limitations and regulatory challenges in field performance. Scientists Are Rewriting How Plants Fight Drought and Disease
This narrative review addresses ecological stability limitations, trait trade-offs, and biosafety challenges. The authors note inconsistent …
This research could help grow more food with less water and fewer chemicals by redesigning the tiny organisms that live on plants.
Systematic review links gut dysbiosis to uveitis pathogenesis
Infectious Disease Sys. Review
Systematic review links gut dysbiosis to uveitis pathogenesis Gut health may influence eye inflammation in uveitis
This systematic review summarizes evidence on gut microbiota modulation for uveitis and inflammatory ocular diseases. It synthesizes that gu…
A review links gut bacteria imbalance to uveitis, suggesting eye inflammation may be tied to what's happening in your digestive system.
Nanochitosan-coated NiTi archwires reduced bacterial CFUs versus uncoated controls in a small RCT.
Infectious Disease RCT
Nanochitosan-coated NiTi archwires reduced bacterial CFUs versus uncoated controls in a small RCT. New Coating Slashes Cavity-Causing Bacteria on Braces
This randomized controlled trial enrolled 30 patients in an oral cavity setting. Over six weeks, nanochitosan-coated nickel-titanium (NiTi) …
This new wire coating could help millions with braces keep their teeth healthy.
Systematic review shows rapid diagnostic tests offer faster, cheaper HIV detection for LAI-PrEP users with low certainty evidence.
Infectious Disease Meta-analysis
Systematic review shows rapid diagnostic tests offer faster, cheaper HIV detection for LAI-PrEP users with low certainty evidence. Rapid tests find HIV just as well as lab tests but cost less and work faster.
This systematic review and meta-analysis evaluated HIV detection strategies, including rapid diagnostic tests (RDTs), laboratory-based immun…
For people on long-acting HIV prevention, rapid tests match lab accuracy while cutting costs and speeding up treatment starts.
Remdesivir reduces COVID-19 hospitalization or death risk in high-risk outpatients
Infectious Disease RCT
Remdesivir reduces COVID-19 hospitalization or death risk in high-risk outpatients Remdesivir may cut hospitalization risk for high-risk COVID outpatients
This Bayesian reanalysis of a Phase 3 RCT in high-risk outpatients with COVID-19 found a posterior median hazard ratio of 0.13 for COVID-19-…
A reanalysis of trial data suggests remdesivir sharply lowers the chance of hospitalization or death for high-risk COVID patients treated at…
Sedentary Behavior in Pregnancy Linked to Gut Microbiota Composition in Small Cohort
Infectious Disease Cohort
Sedentary Behavior in Pregnancy Linked to Gut Microbiota Composition in Small Cohort Sitting Too Much Changes Your Gut Bacteria
This preliminary cohort study of 68 pregnant women found that objectively measured sedentary time during the second and third trimesters was…
Imagine carrying a baby while sitting at a desk all day.